Imaged-based high-throughput screening for anti-angiogenic drug discovery

Area of Science:

• Drug Discovery
• Cell Biology
• Biotechnology

Background:

• High-content screening (HCS) offers a powerful approach for anti-angiogenic drug discovery.
• HCS combines high-throughput methods with automated microscopy for quantitative data acquisition.
• Organotypic systems using primary vascular cells effectively model angiogenesis.

Purpose of the Study:

• To review recent advancements in automated image-based HCS for anti-angiogenic compound discovery.
• To highlight the application of HCS in both in vitro and in vivo models.

Main Methods:

• Utilizing automated multicolor fluorescence microscopy for data collection.
• Employing organotypic systems with primary vascular cells.
• Adapting HCS to high-throughput formats for large-scale chemical library screening.
• Extending HCS principles to in vivo model organisms like zebrafish.

Main Results:

• HCS enables quantitative morphological and molecular data collection from complex biological systems.
• Automated image acquisition facilitates large-scale screening campaigns.
• HCS is applicable to both in vitro and in vivo models for drug discovery.

Conclusions:

• Recent HCS developments provide an attractive platform for anti-angiogenic drug discovery.
• Automated image-based HCS is a key technology for screening chemical libraries.
• The integration of HCS with various biological models enhances its utility in identifying therapeutic compounds.